These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 10400832

  • 21. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
    Micheletto C, Visconti M, Tognella S, Trevisan F, Dal Negro RW.
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
    [Abstract] [Full Text] [Related]

  • 22. The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions.
    Berges-Gimeno MP, Simon RA, Stevenson DD.
    Clin Exp Allergy; 2002 Oct; 32(10):1491-6. PubMed ID: 12372130
    [Abstract] [Full Text] [Related]

  • 23. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C, Tognella S, Visconti M, Trevisan F, Dal Negro RW.
    Respir Med; 2006 Dec; 100(12):2144-50. PubMed ID: 16678396
    [Abstract] [Full Text] [Related]

  • 24. A comparative study of eicosanoid concentrations in sputum and urine in patients with aspirin-intolerant asthma.
    Higashi N, Taniguchi M, Mita H, Osame M, Akiyama K.
    Clin Exp Allergy; 2002 Oct; 32(10):1484-90. PubMed ID: 12372129
    [Abstract] [Full Text] [Related]

  • 25. Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma.
    Sladek K, Szczeklik A.
    Eur Respir J; 1993 Mar; 6(3):391-9. PubMed ID: 8386106
    [Abstract] [Full Text] [Related]

  • 26. Increased exhaled cysteinyl-leukotrienes and 8-isoprostane in aspirin-induced asthma.
    Antczak A, Montuschi P, Kharitonov S, Gorski P, Barnes PJ.
    Am J Respir Crit Care Med; 2002 Aug 01; 166(3):301-6. PubMed ID: 12153961
    [Abstract] [Full Text] [Related]

  • 27. Aspirin-induced asthma: new insights into pathogenesis and clinical presentation of drug intolerance.
    Szczeklik A.
    Int Arch Allergy Appl Immunol; 1989 Aug 01; 90 Suppl 1():70-5. PubMed ID: 2693369
    [Abstract] [Full Text] [Related]

  • 28. Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma.
    Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A.
    Am J Respir Cell Mol Biol; 2000 Sep 01; 23(3):290-6. PubMed ID: 10970818
    [Abstract] [Full Text] [Related]

  • 29. [Aspirin and other nonsteroidal anti-inflammatory drugs hypersensitivity--mechanisms, diagnostics and treatment].
    Kupczyk M, Kuna P.
    Pneumonol Alergol Pol; 2008 Sep 01; 76(5):366-77. PubMed ID: 19003768
    [Abstract] [Full Text] [Related]

  • 30. Effect of inhalation aspirin challenge on exhaled nitric oxide in patients with aspirin-inducible asthma.
    Rolla G, Di Emanuele A, Dutto L, Marsico P, Nebiolo F, Corradi F, Brussino L, Bucca C.
    Allergy; 2004 Aug 01; 59(8):827-32. PubMed ID: 15230814
    [Abstract] [Full Text] [Related]

  • 31. Clinical benefits of aspirin desensitization in patients with nonsteroidal anti-inflammatory drug exacerbated respiratory disease are not related to urinary eicosanoid release and are accompanied with decreased urine creatinine.
    Makowska JS, Olszewska-Ziąber A, Bieńkiewicz B, Lewandowska-Polak A, Kurowski M, Woźniakowski B, Rotkiewicz A, Kowalski ML.
    Allergy Asthma Proc; 2016 May 01; 37(3):216-24. PubMed ID: 27178890
    [Abstract] [Full Text] [Related]

  • 32. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge.
    Kupczyk M, Kurmanowska Z, Kupryś-Lipińska I, Bocheńska-Marciniak M, Kuna P.
    Respir Med; 2010 Oct 01; 104(10):1404-9. PubMed ID: 20452758
    [Abstract] [Full Text] [Related]

  • 33. [Serum phospholipase A2 activity in patients with aspirin-induced asthma].
    Toyoshima M, Sato A, Taniguchi M, Imokawa S, Nakazawa K, Hayakawa H, Chida K.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jul 01; 33(7):691-4. PubMed ID: 7563992
    [Abstract] [Full Text] [Related]

  • 34. A new insight into aspirin-induced asthma.
    Jawien J.
    Eur J Clin Invest; 2002 Feb 01; 32(2):134-8. PubMed ID: 11895461
    [Abstract] [Full Text] [Related]

  • 35. Effect of endobronchial aspirin challenge on inflammatory cells in bronchial biopsy samples from aspirin-sensitive asthmatic subjects.
    Nasser S, Christie PE, Pfister R, Sousa AR, Walls A, Schmitz-Schumann M, Lee TH.
    Thorax; 1996 Jan 01; 51(1):64-70. PubMed ID: 8658372
    [Abstract] [Full Text] [Related]

  • 36. [Aspirin-induced asthma as an important type of bronchial asthma].
    Sakakibara H, Suetsugu S.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Dec 01; 33 Suppl():106-15. PubMed ID: 8752493
    [Abstract] [Full Text] [Related]

  • 37. [Asthma with hypersensitivity to aspirin].
    Nizankowska-Mogilnicka E.
    Pol Merkur Lekarski; 2003 Jun 01; 14(84):561-5. PubMed ID: 14524272
    [Abstract] [Full Text] [Related]

  • 38. Gene-expression profiles in human nasal polyp tissues and identification of genetic susceptibility in aspirin-intolerant asthma.
    Sekigawa T, Tajima A, Hasegawa T, Hasegawa Y, Inoue H, Sano Y, Matsune S, Kurono Y, Inoue I.
    Clin Exp Allergy; 2009 Jul 01; 39(7):972-81. PubMed ID: 19489917
    [Abstract] [Full Text] [Related]

  • 39. Release of peptide leukotriene into nasal secretions after local instillation of aspirin in aspirin-sensitive asthmatic patients.
    Picado C, Ramis I, Rosellò J, Prat J, Bulbena O, Plaza V, Montserrat JM, Gelpí E.
    Am Rev Respir Dis; 1992 Jan 01; 145(1):65-9. PubMed ID: 1309968
    [Abstract] [Full Text] [Related]

  • 40. PGE suppresses excessive anti-IgE induced cysteinyl leucotrienes production in mast cells of patients with aspirin exacerbated respiratory disease.
    Wang XS, Wu AY, Leung PS, Lau HY.
    Allergy; 2007 Jun 01; 62(6):620-7. PubMed ID: 17508965
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.